Progress in fighting systemic fungal infections in haematological neoplasia

Supportive Care in Cancer

Volumn 6, Issue 1, 1997, Pages 31-38

  De Pauw, Ben E ^a   Meis, Jacques F G M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Amphotericin B; Fluconazole; Fungal infection; Itraconazole; Neutropenia

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CREATININE; ECHINOCANDIN B DERIVATIVE; FLUCONAZOLE; FLUCYTOSINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; ITRACONAZOLE; KETOCONAZOLE; LIPOSOME; NYSTATIN; PNEUMOCANDIN DERIVATIVE; PRADIMICIN DERIVATIVE; TERBINAFINE; UNCLASSIFIED DRUG; VORICONAZOLE;

ASPERGILLUS FUMIGATUS; CANDIDA; CLINICAL FEATURE; CLINICAL TRIAL; DRUG FORMULATION; HEMATOLOGIC DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG ASPERGILLOSIS; MALIGNANT NEOPLASTIC DISEASE; MYCOSIS; NEPHROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; REVIEW;

EID: 0031892451     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005200050129     Document Type: Review

References (55)

1. Alangaden G, Chandrasekar PH, Bailey E, et al (1994) Antifungal prophylaxis with low-dose fluconazole during bone marrow transplantation. Bone Marrow Transplant 14:919-924
2. Anaissie E, Bodey GP, Kantarjian H, et al (1991) Fluconazole therapy for disseminated candidiasis in patients with leukemia and prior amphotericin B therapy. Am J Med 91:143-150
3. Anaissie EJ, White M, Uzun O, et al (1995) Amphotericin B lipid complex (ABLC) versus amphotericin B (AMB) for the treatment of hematogenous invasive candidiasis: a prospective, randomized, multicenter trial. Abstract book to the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco
4. Anaissie EJ, Darouiche RO, Abi-Said D, et al (1996) Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and a review of the literature. Clin Infect Dis 23:964-972
5. Behre G, Schwartz S, Lenz K, et al (1995) Aerosol amphotericin B inhalations for the prevention of invasive pulmonary aspergillosis in neutropenic cancer patients. Ann Hematol 71:287-291
6. Bodey GP, Bueltmann B, Duguid W, et al (1992) Fungal infections in cancer patients: an international autopsy survey. Eur J Clin Microbiol Infect Dis 11:99-109
7. Boogaerts MA, Verhoef GE, Zachee P, et al (1989) Antifungal prophylaxis with itraconazole in prolonged neutropenia: correlation with plasma levels. Mycoses 32 [Suppl 1]:103-108
8. Büchner T, Silling-Engelhardt G, Fegeler W, Roos N (1995) Early empiric treatment for febrile neutropenia in patients with hematologic malignancies: fluconazole vs amphotericin B/5-flucytosine. Abstract book to the 2nd International Symposium on Febrile Neutropenia, Brussels, abstract 100
9. Burnie JP, Odds F, Lee W, et al (1985) Outbreak of systemic Candida albicans in intensive care unit caused by cross infection. Br Med J 290:746
10. Caillot D, Cassanovas O, Solary E, et al (1993) Efficacy and tolerance of of an amphotericin B lipid (intralipid) emulsion on the treatment of candidaemia in neutropenic patients. J Antimicrob Chemother 31:161-169
11. Conneally E, Cafferkey MT, Daly PA, et al (1990) Nebulized amphotericin B as prophylaxis against invasive aspergillosis in granulocytopenic patients. Bone Marrow Transplant 5:403-406
12. Cowie F, Meller ST, Cushing P, Pinkerton R (1994) Chemoprophylaxis for pulmonary aspergillosis during intensive chemotherapy. Arch Dis Child 70:136-138
13. Denning DW (1991) Epidemiology and pathogenesis of systemic fungal infections in the immunocompromised host. J Antimicrob Chemother 28 [Suppl B]:1-16
14. Denning DW, Lee JY, Hosteller JS, et al (1994) NIAID Mycosis Study Group multicenter trial of oral itraconazole therapy for invasive aspergillosis. Am J Med 97:135-144
15. De Pauw BE, Raemaekers JMM, Donnelly JP, et al (1995) An open study on the safety and efficacy of fluconazole in the treatment of disseminated Candida infections in patients treated for a hematological malignancy.Ann Hematol 70:83-87
16. Edwards JE (1997) International Conference for the Development of a Consensus on the Management of Severe Candidal Infections. Clin Infect Dis 24 (in press)
17. Ellis ME, Clink H, Ernst P, et al (1994) Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematological malignancies and bone marrow transplant recipients. Eur J Clin Microbiol Infect Dis 13:3-11
18. Ellis M, Spence D, Meunier F, et al (1996) Randomised multicentre trial of 1 mg/kg (LD) versus 4 mg/kg (HD) liposomal amphotericin B (Ambisome) (LAB) in the treatment of invasive aspergillosis (IA). Abstract book to the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, abstract LM39, p 287
19. EORTC International Antimicrobial Therapy Cooperative Group (1989) Empiric antifungal therapy in febrile neutropenic patients. Am J Med 86:668-672
20. Goodman JL, Winston DJ, Greenfield RA, et al (1992) A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 326:845-851
21. Guiot HFL, Fibbe WE, Van 't Wout JW (1994) Risk factors for fungal infection in patients with malignant hematological disorders: implications for empirical therapy and prophylaxis. Clin Infect Dis 18:525-532
22. Guiot HFL, Fibbe WE, Van 't Wout JW (1996) Prevention of invasive candidiasis by fluconazole in patients with malignant hematological disorders and a high grade of Candida colonization. Abstract book to the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, abstract LM33, p 286
23. Gutiérrez F, Wall PG, Cohen J (1996) An audit on the use of antifungal agents. J Antimicrob Chemother 37:175-185
24. Hertenstein B, Kern WV, Schmeiser T, et al (1994) Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia. Ann Hematol 68:21-26
25. Jeffery GM, Beard, MEJ, Ikram RB, et al (1991) Intranasal amphotericin B reduces the frequency of invasive aspergillosis in neutropenic patients. Am J Med 90:685-692
26. Karp JE, Burch PA, Merz WG (1988) An approach to intensive antileukemic therapy in patients with previous invasive aspergillosis. Am J Med 85:203-206
27. Kaufman CA, Bradley SF, Ross SC, Weber DR (1991) Hepatosplenic candidiasis: successful treatment with fluconazole. Am J Med 91:137-141
28. Kennedy MJ, Volz PA (1985) Ecology of Candida albicans gut colonization: inhibition of Candida adhesion, colonization, and dissemination from the gastrointestinal tract by bacterial antagonism. Infect Immun 49:654-663
29. Lecciones JA, Lee JW, Navarro EE, et al (1992) Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clin Infect Dis 14:875-883
30. Menichetti F, Del Favero A, Martino P, et al (1994) Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared with oral amphotericin B. Ann Intern Med 120:913-918
31. Morgenstern GR, Prentice AG, Prentice HG, et al (1996) Itraconazole (IT) oral solution vs fluconazole (F) suspension for antifungal prophylaxis in neutropenic patients. Abstract book to the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, abstract LM34, p 286
32. Morrison VA, Haake RJ, Weisdorf DJ (1994) Non-candidal fungal infections after bone marrow transplantation: risk factors and outcome. Am J Med 96:497-503
33. Nosari A, Cantoni S, Muti G, et al (1994) Itraconazole in leukemic patients with invasive aspergillosis (IA): impact on intensive chemotherapy completion. Eur J Haematol 53:183-185
34. O'Donnell MR, Schmidt GM, Tegtmeier BR, et al (1994) Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients. J Clin Oncol 12:827-834
35. Oppenheim BA, Herbrecht R, Kusne S (1995) The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses. Clin Infect Dis 21:1145-1153
36. Oven WJG, Claessens RAMJ, Raemaekers JMM, et al (1992) Diagnosing infection in febrile granulocytopenic patients with indium-111 labelled human immunoglobulin G. J Clin Oncol 10:61-68
37. Perfect J, Klotman ME, Gilbert CC, et al (1992) Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients. J Infect Dis 165:891-897
38. Pizzo PA, Robichaud KJ, Gill FA, Witebsky FG (1982) Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 72:101-110
39. Prentice AG, Bradford GR (1989) Prophylaxis of fungal infections with itraconazole during remission induction therapy. Mycoses 32 [Suppl 1]:96-102
40. Prentice AG, Warnock DW, Johnson SA, et al (1994) Multiple dose pharmacokinetics of an oral solution of itraconazole in autologous bone marrow transplant recipients. J Antimicrob Chemother 34:247-252
41. Prentice HG, Catovsky D, Aoun M, et al (1995) Ambisome versus amphotericin B patients, with fever unresponsive to antibiotic therapy for 96 hours, or with confirmed fungal infection. Abstract book to the 2nd International Symposium on Febrile Neutropenia, Brussels, abstract 35
42. Riley DK, Pavia AT, Beatty PG, et al (1994) The prophylactic use of low-dose amphotericin B in bone marrow transplant patients. Am J Med 97:509-514
43. Sanford GR, Merz WG, Wingard JR, et al (1980) The value of surveillance cultures as predictors of systemic fungal infections. J Infect Dis 142:503-509
44. Schöffski P, Wunder R, Petersen D, et al (1996) Amphotericin B in Intralipid: no evidence of improved toxicity profile. Results of a randomized phase II-trial in neutropenic patients. Abstract book to the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, abstract LM36, p 287
45. Slavin MA, Osborne B, Adams R, et al (1995) Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation - a prospective, randomized double blind study. J Infect Dis 171:1545-1552
46. Verweij PE, Stynen D, Rijs AJMM, et al (1995) Sandwich enzyme-linked immunoassay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients. J Clin Microbiol 33:1912-1914
47. Verweij PE, Latgé JP, Rijs AJMM, et al (1995) Comparison of antigen detection and PCR assay with bronchoalveolar lavage fluid for diagnosing invasive aspergillosis in patients receiving treatment for hematological malignancies. J Clin Microbiol 33:3150-3153
48. Verweij PE, Meis FFGM, Van den Hurk P, et al (1995) Polymerase chain reaction as a diagnostic tool for invasive aspergillosis: evaluation in bronchoalveolar lavage fluid from low risk patients. Serodiagn Immunother Infect Dis 6:203-208
49. Viscoli C, Castagnola E, Fioredda F, et al (1991) Fluconazole in the treatment of candidiasis in immunocompromised children. Antimicrob Agents Chemother 35:365-367
50. Viscoli C, Castagnola E, Van Lint MT, et al (1996) Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomized trial. Eur J Cancer [A] 32:814-820
51. Vreugdenhil G, Van Dijke BJ, Donnelly JP, et al (1993) Efficacy of itraconazole in the prevention of fungal infections among neutropenic patients with hematological malignancies and intensive chemotherapy. A double blind, placebo controlled study. Leuk Lymph 11:353-358
52. Walsh TJ, Hiemenz J, Seibel E, Anaissie EJ (1994) Amphotericin B lipid complex in the treatment of 228 cases of invasive mycosis. Abstract book to the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy
53. Wingard JR, Merz WG, Rinaldi MG, et al (1991) Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 325:1274-1277
54. Wingard JR, Merz WG, Rinaldi MG, et al (1993) Association of Torulopsis glabrata infections in neutropenic bone marrow transplantation patients. Antimicrob Agents Chemother 37:1847-1849
55. Winston DW, Chandrasekar PH, Lazarus HM, et al (1993) Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double blind, multicenter trial. Ann Intern Med 118:495-503